Nuvectis Pharma Inc (NVCT) — Financial Flexibility Index
Latest as of September 2025:
-0.39x
Nuvectis Pharma Inc (NVCT) has a Financial Flexibility Index of -0.39x as of September 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents 0% of total liabilities ($11.58 Million).
Financial Flexibility Index
-0.39x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-4.49 Million
Operating CF − Capex
Total Liabilities
$11.58 Million
USD
Capital Expenditures
$0.00
USD
Nuvectis Pharma Inc Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Nuvectis Pharma Inc across 5 annual periods. See Nuvectis Pharma Inc (NVCT) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nuvectis Pharma Inc (2020–2024)
Year-by-year free cash flow to debt coverage for Nuvectis Pharma Inc. For the full company profile including market capitalisation, see NVCT market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.38x | $-12.25 Million | $-12.25 Million | $8.89 Million | ▲ +39.7% |
| 2023 | -2.28x | $-15.95 Million | $-15.95 Million | $6.98 Million | ▼ -4.2% |
| 2022 | -2.19x | $-13.56 Million | $-13.56 Million | $6.19 Million | ▼ -307.4% |
| 2021 | -0.54x | $-9.50 Million | $-9.50 Million | $17.66 Million | ▼ -122.4% |
| 2020 | 2.40x | $24.00K | $24.00K | $10.00K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities